Eden Innovations Posts 50% FY25 US Sales Increase, Boosts Pz7 Capacity 500%
Eden Innovations reports a striking 114% year-on-year jump in Q4 US sales of its EdenCrete® products, alongside a 50% annual sales increase and significant debt reduction plans.
- 114% increase in Q4 2025 EdenCrete® product sales in the US
- 50% growth in total FY25 US product sales to approximately AUD 2.3 million
- Record Pz7 sales and 16 ready-mix concrete plants equipped globally
- 500% expansion in EdenCrete® Pz7 production capacity
- Planned AUD 6.6 million entitlement offer and US property sales to reduce debt
Robust US Sales Drive Growth
Eden Innovations Ltd (ASX – EDE) has delivered a compelling performance in the quarter ended 30 June 2025, with its US subsidiary, Eden USA, recording the second highest quarterly sales ever. Total product sales reached US$360,000 (approx. AUD$562,000), driven by a remarkable 114% increase in EdenCrete® product sales compared to the same quarter last year. This momentum contributed to a 50% rise in total US sales for the full financial year 2025, reaching approximately US$1.46 million (AUD$2.3 million).
The surge was largely powered by EdenCrete® Pz7, a high-performance concrete additive, which achieved record quarterly sales of US$223,000 (AUD$350,000). The company expanded its footprint with 12 new ready-mix concrete plant installations during the quarter, bringing the global total to 16 plants equipped with Pz7 dispensing systems, including significant growth in Colorado, USA, and Ecuador.
Scaling Production to Meet Demand
To support this rapid uptake, Eden Innovations optimized its Pz7 production process, increasing capacity by an impressive 500%. This enhancement enables the company to produce approximately US$12 million (AUD$18.5 million) worth of Pz7 annually on a single shift basis, with potential for further expansion through additional shifts or equipment duplication.
Major projects utilizing EdenCrete® Pz7 are underway, including the Bellview Station Block F in Denver, a 22-story mixed-use development, and the I-70 Floyd Hill infrastructure project in Colorado, valued at US$905 million. These projects underscore the product’s growing acceptance in commercial and infrastructure applications.
International Expansion and Product Mix
Internationally, Eden has secured orders from Holcim Group subsidiaries in Ecuador, Mexico, and Canada, with Ecuador alone contributing US$356,000 in orders. Trials continue in India, where the Central Road Research Institute is evaluating EdenCrete® Pz7’s suitability for highway and bridge construction, tapping into one of the world’s fastest-growing concrete markets.
The company’s OptiBlend® dual fuel system also posted strong growth, with US sales increasing 73% year-on-year to AUD$929,000, reflecting rising global interest in cleaner, more efficient fuel solutions for industrial applications.
Balance Sheet Strengthening Initiatives
On the financial front, Eden Innovations is proactively addressing its debt profile. The company plans a renounceable pro-rata entitlement offer on a 1-for-2 basis to raise up to AUD 6.6 million, alongside a 1-for-20 security consolidation. These moves aim to repay major shareholder loans totaling AUD 7.5 million and provide working capital for continued global expansion.
Additionally, Eden expects to complete the sale of a Georgia, US property for US$5 million in late August 2025, which will repay approximately 70% of its US bank loan, significantly lowering borrowing costs. Another property in Littleton, Colorado, remains on the market, with its sale anticipated to enable the company to become debt-free.
Cash Flow and Outlook
Despite a negative operating cash flow of AUD 936,000 for the quarter, Eden Innovations holds AUD 561,000 in cash and anticipates improved liquidity following debt reduction and sales growth. The company expects to maintain current operating costs while increasing revenue, aiming for neutral cash flow in the near term.
Overall, Eden Innovations is demonstrating strong commercial traction in its core US market, expanding international reach, and taking decisive steps to strengthen its financial position, setting the stage for sustained growth.
Bottom Line?
Eden’s robust sales and strategic debt reduction position it well for scaling global market penetration in the year ahead.
Questions in the middle?
- Will the entitlement offer fully meet Eden’s capital needs to sustain growth?
- How quickly will the sale of the Colorado property close, and what impact will it have on debt levels?
- Can Eden maintain its rapid production scale-up without compromising product quality or margins?